Skip to search formSkip to main contentSkip to account menu

KRM 1668

Known as: KRM-1668, Rifamycin VIII, 1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(1-methylpropyl)-1-piperazinyl)-1-oxo- 
National Institutes of Health

Related topics

Related topics

2 relations
KRM 1686

Broader (1)

Rifamycins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
Comparative activities of various rifamycin analogues against leprosy were studied by evaluating their effects on in vitro growth… 
1995
1995
The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
The activities of four newly synthesized benzoxazinorifamycin derivatives, either alone or in combination with ofloxacin, against… 
Review
1991
Review
1991
[Antimycobacterial activities of rifamycin derivatives].
  • F. Kuze
  • Kekkaku : [Tuberculosis]
  • 1991
  • Corpus ID: 45938345
The Standard Initial Chemotherapy, chemotherapeutic activity of which depends mostly on the two potent bactericidal drugs, INH… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)